Intelligent Formulation Design and Evaluation for SWIFT Product Development

3/17/2021 10:25 - 11:00

While in vitro testing of formulations provides a good initial indication of how a product should perform, the complexities and variability in the GI tract are difficult to model and so clinical success is not always guaranteed. Intelligent formulation design, integrating biopharmaceutics and adaptive clinical testing can accelerate the successful development new products.

Dr Fiona MacDougall, Director of Biopharmaceutics, BDD